# Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study

> **NCT00708396** · PHASE4 · UNKNOWN · sponsor: **BeerYaakov Mental Health Center** · enrollment: 20 (estimated)

## Conditions studied

- OCD
- Schizophrenia

## Interventions

- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT00708396
- **Lead sponsor:** BeerYaakov Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708396, "Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00708396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*